NFKB1 and diabetes mellitus: Kaempferol upregulates SIRT1 (161), inhibits NF-κB nuclear translocation, and activates nuclear factor E2-related factor (162), thereby inhibiting diabetes-induced myocardial inflammation and oxidative stress.